#moderna
11 stories
Merck CEO: Cancer Vaccine Manufacturing Timeline Shortens
Merck CEO says cancer vaccine production will speed up over time with Moderna.
CNBC · 1m
Moderna Shares Jump After Citigroup Downgrade
Moderna stock surges 6.7% as Citigroup lifts price target to $80.
Alphastreet - Earnings Decoded. Market Intelligence Delivered · 1m
Flu shot timing matters this year
An early flu wave is spreading across the US, and doctors say October is the ideal time to get vaccinated before cases peak.
TIME · 2m
Moderna Stock Rises 6% on Cancer Vaccine Data
Moderna stock climbs 6% after melanoma vaccine data shows 49% lower recurrence risk.
Yahoo Finance · 2m
mFlusiva mRNA flu vaccine ready for 50+
Moderna's new mRNA flu shot mFlusiva is ready for people 50 and older, offering faster production and better flu protection.
The Banner · 1m
S&P 500 and Nasdaq Outperform Tough September
Stocks weathered September's volatility as inflation data and election season boost Q4 prospects.
Kiplinger · 1m
CDC FDA Gave All-Clear When They Knew It Wasn't
CDC and FDA claimed vaccines safe despite missing myocarditis alerts, while Pfizer and Moderna earned tens of billions.
Wellbeing Magazine · 1m
Moderna Jumps 9% After Melanoma Data Wins Prestigious Slot
Moderna stock surges 9% as Phase 3 melanoma trial data secures top presentation slot at major cancer conference
24/7 Wall St. · 1m
Moderna Rises 6% in Biotech Rally
Moderna jumps 6% as biotech stocks surge in coordinated sector move
Alphastreet - Earnings Decoded. Market Intelligence Delivered · 1m
What We Tell Our Kids About AI
Parents in medicine see real breakthroughs alongside genuine risks, and think kids deserve to hear both.
TIME · 2m
RSV vaccines prove highly effective in older adults
New real-world data confirms RSV shots reduce hospitalizations and deaths by 80% in seniors.
TIME · 1m